Bifidobacterium bifidum as an example of a specialized human gut commensal

Frontiers in Microbiology

Volumn 5, Issue AUG, 2014, Pages

  Turroni, Francesca ^a   Duranti, Sabrina ^b   Bottacini, Francesca ^a   Guglielmetti, Simone ^c   Van Sinderen, Douwe ^a   Ventura, Marco ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bifidobacteria; Bifidobacterium bifidum; Genomics; Microbiota; Probiotics

Indexed keywords

ABC TRANSPORTER; CARBOHYDRATE BINDING PROTEIN; COLLAGEN; FIBRONECTIN; FUCOSE; GLYCAN DERIVATIVE; GLYCOPROTEIN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; LAMININ; MUCIN; MYELOPEROXIDASE; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; PHOSPHOENOLPYRUVATE SUGAR PHOSPHOTRANSFERASE; PILIN; PROBIOTIC AGENT; PROSTAGLANDIN SYNTHASE; RNA 16S; SCLEROPROTEIN;

AKKERMANSIA MUCINIPHILA; APOPTOSIS; ARTICLE; BACTERIAL GENE; BIFIDOBACTERIUM BIFIDUM; CARBOHYDRATE METABOLISM; CRONOBACTER SAKAZAKII; DOWN REGULATION; ESCHERICHIA COLI; FECES MICROFLORA; GENE SEQUENCE; GENETIC VARIABILITY; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; MICROBIAL DIVERSITY; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; UPREGULATION;

BIFIDOBACTERIUM BIFIDUM;

EID: 84922297921     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00437     Document Type: Article

References (78)

1. Ashida, H., Maki, R., Ozawa, H., Tani, Y., Kiyohara, M., Fujita, M., et al. (2008). Characterization of two different endo-alpha-N-acetylgalactosaminidases from probiotic and pathogenic enterobacteria, Bifidobacterium longum and Clostridium perfringens. Glycobiology 18, 727-734. doi: 10.1093/glycob/cwn053.
2. Ashida, H., Miyake, A., Kiyohara, M., Wada, J., Yoshida, E., Kumagai, H., et al. (2009). Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19, 1010-1017. doi: 10.1093/glycob/cwp082.
3. Barrangou, R., Briczinski, E.P., Traeger, L.L., Loquasto, J.R., Richards, M., Horvath, P., et al. (2009). Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. J. Bacteriol. 191, 4144-4151. doi: 10.1128/JB. 00155-09.
4. Bottacini, F., Dal Bello, F., Turroni, F., Milani, C., Duranti, S., Foroni, E., et al. (2011). Complete genome sequence of Bifidobacterium animalis subsp. lactis BLC1. J. Bacteriol. 193, 6387-6388. doi: 10.1128/JB. 06079-11.
5. Bottacini, F., Milani, C., Turroni, F., Sanchez, B., Foroni, E., Duranti, S., et al. (2012). Bifidobacterium asteroides PRL2011 genome analysis reveals clues for colonization of the insect gut. PLoS ONE 7:e44229. doi: 10.1371/journal.pone. 0044229.
6. Buchanan, R.E. (2009). Bergey's Manual of Systematic Bacteriology, ed. N. E. Gibbons. New York: Springer.
7. Caballero-Franco, C., Keller, K., De Simone, C., and Chadee, K. (2007). The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G315-G322. doi: 10.1152/ajpgi.00265.2006.
8. Cantarel, B.L., Coutinho, P.M., Rancurel, C., Bernard, T., Lombard, V., and Henrissat, B. (2009). The Carbohydrate-Active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res. 37, D233-D238. doi: 10.1093/nar/gkn663.
9. Chenoll, E., Casinos, B., Bataller, E., Astals, P., Echevarria, J., Iglesias, J.R., et al. (2011). Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Appl. Environ. Microbiol. 77, 1335-1343. doi: 10.1128/AEM. 01820-10.
10. Deivanayagam, C.C., Rich, R.L., Carson, M., Owens, R.T., Danthuluri, S., Bice, T., et al. (2000). Novel fold and assembly of the repetitive B region of the Staphylococcus aureus collagen-binding surface protein. Structure 8, 67-78. doi: 10.1016/S0969-2126(00)00081-2.
11. Delcenserie, V., Taminiau, B., Gavini, F., De Schaetzen, M.A., Cleenwerck, I., Theves, M., et al. (2013). Detection and characterization of Bifidobacterium crudilactis and B. mongoliense able to grow during the manufacturing process of French raw milk cheeses. BMC Microbiol. 13:239. doi: 10.1186/1471-2180-13-239.
12. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638. doi: 10.1126/science.1110591.
13. Egan, M., O'connell Motherway, M., Ventura, M., and Van Sinderen, D. (2014). Metabolism of sialic acid by Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 80, 4414-4426. doi: 10.1128/AEM. 01114-14.
14. Farfan, M.J., Cantero, L., Vidal, R., Botkin, D.J., and Torres, A.G. (2011). Long polar fimbriae of enterohemorrhagic Escherichia coli O157:H7 bind to extracellular matrix proteins. Infect. Immun. 79, 3744-3750. doi: 10.1128/IAI. 05317-11.
15. Foroni, E., Serafini, F., Amidani, D., Turroni, F., He, F., Bottacini, F., et al. (2011). Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microb. Cell Fact. 10(Suppl. 1), S16. doi: 10.1186/1475-2859-10-S1-S16.
16. Forstner, J.F., Oliver., M.G., and Sylvester, F.A. (1995). Production, Structure and Biologic Relevance of Gastrointestinal Mucins. New York: Raven Press.
17. Fu, Y.R., Yi, Z.J., Pei, J.L., and Guan, S. (2010). Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Microbiol. Immunol. 54, 578-583. doi: 10.1111/j.1348-0421.2010.00255.x.
18. Galdeano, C.M., De Moreno De Leblanc, A., Vinderola, G., Bonet, M.E., and Perdigon, G. (2007). Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 14, 485-492. doi: 10.1128/CVI. 00406-06.
19. Gleinser, M., Grimm, V., Zhurina, D., Yuan, J., and Riedel, C.U. (2012). Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA. Microb. Cell Fact. 11, 80. doi: 10.1186/1475-2859-11-80s.
20. Gonzalez-Rodriguez, I., Sanchez, B., Ruiz, L., Turroni, F., Ventura, M., Ruas-Madiedo, P., et al. (2012). Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Appl. Environ. Microbiol. 78, 3992-3998. doi: 10.1128/AEM. 08024-11.
21. Guglielmetti, S., Balzaretti, S., Taverniti, V., Miriani, M., Milani, C., Scarafoni, A., et al. (2014a). Characterization of TgaA, a VirB1-like component belonging to a putative type IV secretion system of Bifidobacterium bifidum MIMBb75. Appl. Environ. Microbiol. doi: 10.1128/AEM. 01413-14 [Epub ahead of print].
22. Guglielmetti, S., Zanoni, I., Balzaretti, S., Miriani, M., Taverniti, V., De Noni, I., et al. (2014b). The murein lytic enzyme TgaA of Bifidobacterium bifidum MIMBb75 modulates dendritic cell maturation through its CHAP amidase domain. Appl. Environ. Microbiol. doi: 10.1128/AEM. 00761-14 [Epub ahead of print].
23. Guglielmetti, S., Ciranna, A., Mora, D., Parini, C., and Karp, M. (2008a). Construction, characterization and exemplificative application of bioluminescent Bifidobacterium longum biovar longum. Int. J. Food Microbiol. 124, 285-290. doi: 10.1016/j.ijfoodmicro.2008.03.033.
24. Guglielmetti, S., Tamagnini, I., Mora, D., Minuzzo, M., Scarafoni, A., Arioli, S., et al. (2008b). Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl. Environ. Microbiol. 74, 4695-4702. doi: 10.1128/AEM. 00124-08.
25. Guglielmetti, S., Fracassetti, D., Taverniti, V., Del Bo, C., Vendrame, S., Klimis-Zacas, D., et al. (2013). Differential modulation of human intestinal Bifidobacterium populations after consumption of a wild blueberry (Vaccinium angustifolium) drink. J. Agric. Food Chem. 61, 8134-8140. doi: 10.1021/jf402495k.
26. Guglielmetti, S., Mora, D., Gschwender, M., and Popp, K. (2011). Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life - a double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 33, 1123-1132. doi: 10.1111/j.1365-2036.2011.04633.x.
27. Guglielmetti, S., Tamagnini, I., Minuzzo, M., Arioli, S., Parini, C., Comelli, E., et al. (2009). Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines. Curr. Microbiol. 59, 167-172. doi: 10.1007/s00284-009-9415-x.
28. Harmsen, H.J., Wildeboer-Veloo, A.C., Raangs, G.C., Wagendorp, A.A., Klijn, N., Bindels, J.G., et al. (2000). Analysis of intestinal flora development in breast-fed and formula-fed infantsbyusing molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30, 61-67. doi: 10.1097/00005176-200001000-00019.
29. Hooper, L.V., Xu, J., Falk, P.G., Midtvedt, T., and Gordon, J.I. (1999). A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. U.S.A. 96, 9833-9838. doi: 10.1073/pnas.96.17.9833.
30. Jayamanne,V. S., and Adams, M.R. (2006). Determination of survival, identity and stress resistance of probiotic bifidobacteria in bio-yoghurts. Lett. Appl. Microbiol. 42, 189-194. doi: 10.1111/j.1472-765X. 2006.01843.x.
31. Johansson, M.E., Phillipson, M., Petersson, J., Velcich, A., Holm, L., and Hansson, G.C. (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. U.S.A. 105, 15064-15069. doi: 10.1073/pnas.0803124105.
32. Kainulainen, V., Reunanen, J., Hiippala, K., Guglielmetti, S., Vesterlund, S., Palva, A., et al. (2013). BopA does not have a major role in the adhesion of Bifidobacterium bifidum to intestinal epithelial cells, extracellular matrix proteins, and mucus. Appl. Environ. Microbiol. 79, 6989-6997. doi: 10.1128/AEM. 01993-13.
33. Khailova, L., Mount Patrick, S.K., Arganbright, K.M., Halpern, M.D., Kinouchi, T., and Dvorak, B. (2010). Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1118-G1127. doi: 10.1152/ajpgi.00131.2010.
34. Kiyohara, M., Nakatomi, T., Kurihara, S., Fushinobu, S., Suzuki, H., Tanaka, T., et al. (2012). Alpha-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway. J. Biol. Chem. 287, 693-700. doi: 10.1074/jbc.M111.277384.
35. Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., et al. (2011). Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4578-4585. doi: 10.1073/pnas.1000081107.
36. Lamendella, R., Santo Domingo, J.W., Kelty, C., and Oerther, D.B. (2008). Bifidobacteria in feces and environmental waters. Appl. Environ. Microbiol. 74, 575-584. doi: 10.1128/AEM. 01221-07.
37. Lebeer, S., Vanderleyden, J., and De Keersmaecker, S.C. (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8, 171-184. doi: 10.1038/ nrmicro2297.
38. Lee, J.H., Karamychev, V.N., Kozyavkin, S.A., Mills, D., Pavlov, A.R., Pavlova, N.V., et al. (2008). Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 9:247. doi: 10.1186/1471-2164-9-247.
39. Lopez, P., Gonzalez-Rodriguez, I., Gueimonde, M., Margolles, A., and Suarez, A. (2011). Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity. PLoS ONE 6:e24776. doi: 10.1371/journal.pone.0024776.
40. Milani, C., Hevia, A., Foroni, E., Duranti, S., Turroni, F., Lugli, G.A., et al. (2013). Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS ONE 8:e68739. doi: 10.1371/journal.pone.0068739.
41. Mouni, F., Aissi, E., Hernandez, J., Gorocica, P., Bouquelet, S., Zenteno, E., et al. (2009). Effect of Bifidobacterium bifidum DSM 20082 cytoplasmic fraction on human immune cells. Immunol. Invest. 38, 104-115. doi: 10.1080/08820130802608303.
42. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., et al. (2006). Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72, 1027-1033. doi: 10.1128/AEM.72.2.1027-1033.2006.
43. O'Connell Motherway, M., Zomer, A., Leahy, S.C., Reunanen, J., Bottacini, F., Claesson, M.J., et al. (2011). Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc. Natl. Acad. Sci. U.S.A. 108, 11217-11222. doi: 10.1073/pnas.1105380108.
44. Palmer, C., Bik, E.M., Digiulio, D.B., Relman, D.A., and Brown, P.O. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5:e177. doi: 10.1371/journal.pbio.0050177.
45. Philippe, D., Heupel, E., Blum-Sperisen, S., and Riedel, C.U. (2011). Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Int. J. Food Microbiol. 149, 45-49. doi: 10.1016/j.ijfoodmicro.2010.12.020.
46. Podolsky,D. K. (1985). Oligosaccharide structures of isolated human colonic mucin species. J. Biol. Chem. 260, 15510-15515.
47. Roger, L.C., Costabile, A., Holland, D.T., Hoyles, L., and Mccartney, A.L. (2010). Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156, 3329-3341. doi: 10.1099/mic.0.043224-0.
48. Schell, M.A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., et al. (2002). The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. U.S.A. 99, 14422-14427. doi: 10.1073/pnas.212527599212527599.
49. Sela, D.A., Chapman, J., Adeuya, A., Kim, J.H., Chen, F., Whitehead, T.R., et al. (2008). The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U.S.A. 105, 18964-18969. doi: 10.1073/pnas.0809 584105.
50. Serafini, F., Strati, F., Ruas-Madiedo, P., Turroni, F., Foroni, E., Duranti, S., et al. (2013). Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010. Anaerobe 21, 9-17. doi: 10.1016/j.anaerobe.2013.03.003.
51. Serafini, F., Turroni, F., Ruas-Madiedo, P., Lugli, G.A., Milani, C., Duranti, S., et al. (2014). Kefir fermented milk and kefiran promote growth of Bifidobacterium bifidum PRL2010 and modulate its gene expression. Int. J. Food Microbiol. 178, 50-59. doi: 10.1016/j.ijfoodmicro.2014.02.024.
52. Shirasawa, Y., Shibahara-Sone, H., Iino, T., and Ishikawa, F. (2010). Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. J. Dairy Sci. 93, 4526-4534. doi: 10.3168/jds.2010-3274.
53. Singh, N., Arioli, S., Wang, A., Villa, C.R., Jahani, R., Song, Y.S., et al. (2013). Impact of Bifidobacterium bifidum MIMBb75 on mouse intestinal microorganisms. FEMS Microbiol. Ecol. 85, 369-375. doi: 10.1111/1574-6941.12124.
54. Sonnenburg, J.L., Chen, C.T., and Gordon, J.I. (2006). Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 4:e413. doi: 10.1371/journal.pbio.0040413.
55. Stackebrandt, E., and Tindall, B.J. (2000). Appreciating microbial diversity: rediscovering the importance of isolation and characterization of microorganisms. Environ. Microbiol. 2, 9-10.
56. Tabbers, M.M., De Milliano, I., Roseboom, M.G., and Benninga, M.A. (2011). Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutr. J. 10:19. doi: 10.1186/1475-2891-10-19.
57. Telford, J.L., Barocchi, M.A., Margarit, I., Rappuoli, R., and Grandi, G. (2006). Pili in Gram-positive pathogens. Nat. Rev. Microbiol. 4, 509-519. doi: 10.1038/nrmicro1443.
58. Tissier. (1900). Recherchers Sur La Flora Intestinale Normale et Pathologique Du Nourisson. Ph.D. thesis, University of Paris, Paris.
59. Turroni, F., Bottacini, F., Foroni, E., Mulder, I., Kim, J.H., Zomer, A., et al. (2010). Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc. Natl. Acad. Sci. U.S.A. 107, 19514-19519. doi: 10.1073/pnas.1011100107.
60. Turroni, F., Foroni, E., Pizzetti, P., Giubellini, V., Ribbera, A., Merusi, P., et al. (2009a). Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75, 1534-1545. doi: 10.1128/AEM. 02216-08.
61. Turroni, F., Marchesi, J.R., Foroni, E., Gueimonde, M., Shanahan, F., Margolles, A., et al. (2009b). Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J. 3, 745-751. doi: 10.1038/ismej.2009.19.
62. Turroni, F., Milani, C., Van Sinderen, D., and Ventura, M. (2011). Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut Microbes 2, 183-189. doi: 10.4161/gmic.2.3.16105.
63. Turroni, F., Peano, C., Pass, D.A., Foroni, E., Severgnini, M., Claesson, M.J., et al. (2012). Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 7:e36957. doi: 10.1371/journal.pone.0036957.
64. Turroni, F., Serafini, F., Foroni, E., Duranti, S., O'connell Motherway, M., Taverniti, V., et al. (2013a). Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc. Natl. Acad. Sci. U.S.A. 110, 11151-11156. doi: 10.1073/pnas. 1303897110.
65. Turroni, F., Ventura, M., Butto, L.F., Duranti, S., O'toole, P.W., Motherway, M.O., et al. (2013b). Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol. Life Sci. 71, 183-203. doi: 10.1007/s00018-013-1318-0.
66. Turroni, F., Taverniti, V., Ruas-Madiedo, P., Duranti, S., Guglielmetti, S., Lugli, G.A., et al. (2014a). Bifidobacterium bifidum PRL2010 modulates the host innate immune response. Appl. Environ. Microbiol. 80, 730-740. doi: 10.1128/AEM. 03313-13.
67. Turroni, F., Ventura, M., Butto, L.F., Duranti, S., O'Toole, P.W., Motherway, M.O., et al. (2014b). Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell. Mol. Life. Sci. 71, 183-203. doi: 10.1007/s00018-013-1318-0.
68. Ventura, M., Canchaya, C, Fitzgerald, G.F., Gupta, R.S., and Van Sinderen, D. (2007a). Genomics as a means to understand bacterial phylogeny and ecological adaptation: thecase of bifidobacteria. AntonieVan Leeuwenhoek91, 351-372. doi: 10.1007/s10482-006-9122-6.
69. Ventura, M., Canchaya, C., Tauch, A., Chandra, G., Fitzgerald, G.F., Chater, K.F., et al. (2007b). Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol. Mol. Biol. Rev. 71, 495-548. doi: 10.1128/MMBR. 00005-07.
70. Ventura, M., O'flaherty, S., Claesson, M.J., Turroni, F., Klaenhammer, T.R., Van Sinderen, D., et al. (2009a). Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 7, 61-71. doi: 10.1038/nrmicro2047.
71. Ventura, M., Turroni, F., Canchaya, C, Vaughan, E.E., O'toole, P.W., and Van Sinderen, D. (2009b). Microbial diversity in the human intestine and novel insights from metagenomics. Front. Biosci. (Landmark Ed.) 14:3214-3221. doi: 10.2741/3445.
72. Ventura, M., Turroni, F., Foroni, E., Duranti, S., Giubellini, V, Bottacini, F., et al. (2010). Analyses of bifidobacterial prophage-like sequences. Antonie Van Leeuwenhoek 98, 39-50. doi: 10.1007/s10482-010-9426-4.
73. Ventura, M., Turroni, F., Lugli, G.A., and Van Sinderen, D. (2014). Bifidobacteria and humans: our special friends, from ecological to genomics perspectives. J. Sci FoodAgric. 94, 163-168. doi: 10.1002/jsfa.6356.
74. Ventura, M., Turroni, F., Motherway, M.O., Macsharry, J., and Van Sinderen, D. (2012). Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends Microbiol. 20,467-476. doi: 10.1016/j.tim.2012.07.002.
75. Wajant, H., Pfizenmaier, K., and Scheurich, P. (2003). Tumor necrosis factor signaling. Cell Death Differ. 10,45-65. doi: 10.1038/sj.cdd.4401189.
76. Weiss, G., Rasmussen, S., Nielsen Fink, L., Jarmer, H., Nohr Nielsen, B., and Frokiaer, H. (2010). Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells. PLoS ONE 5:e11065. doi: 10.1371/journal.pone.0011065.
77. Yasutake, N., Matsuzaki, T., Kimura, K., Hashimoto, S., Yokokura, T., and Yoshikai, Y (1999). The role of tumor necrosis factor (TNF)-alphain the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice. Med. Microbiol. Immunol. 188, 9-14. doi: 10.1007/s004300050099.
78. Zhang, F., Li, X. Y, Park, H.J., and Zhao, M. (2013). Effect of microencapsulation methods on the survival of freeze-dried Bifidobacterium bifidum. J. Microencapsul. 30, 511-518. doi: 10.3109/02652048.2012.758178.